Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, presenting promising advancements across various healthcare and industrial apps. With its structural similarity to Obviously derived human serum albumin, OsrHSA supplies a safer, much more trustworthy alternate for therapeutic use, s